Philip W. Lavori
Publication Details
-
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.
Clin Lung Cancer. 2012; (1): 52-8
Fluorine-18 flurodeoxyglucose positron emission tomography (FDG-PET) imaging has rapidly become the standard of care for staging patients with lung cancer. We evaluated the prognostic value of metabolic tumor volume (MTV), a measure of tumor burden on FDG-PET imaging, in patients with non-small-cell lung cancer (NSCLC) treated definitively.
Help
Trial Administration